| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5510188 | Clinical Biochemistry | 2017 | 15 Pages |
Abstract
The comparison of two different assays of cTnI against a diagnosis of acute MI (AMI) shows that both assays behave equally well with a high degree of sensitivity and specificity. The resulting “best cut-off” suggests that this AQT90 FLEX cTnI concentration could be evaluated as the potentially new “clinically usable” cut-off for AMI/myocardial necrosis diagnoses.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Monica Maria Mion, Giada Bragato, Alessandra Casarotti, Chiara Cosma, Stefania Vigolo, Gianna Vettore, Franco Tosato, Martina Zaninotto, Mario Plebani,